A Study in Healthy Subjects to Investigate Pharmacokinetics of AZD5423 When Administered in Different Ways

solution for injection, administered as intravenous infusion Corr to total dose of 250 µg AZD5423

nebuliser suspension, inhaled via Spira, corr to approximately 300 µg lung deposited dose AZD5423

nebuliser suspension, inhaled via I-neb, corr to approximately 300 µg lung deposited dose AZD5423

nebuliser suspension to be administered orally, corr to a total dose of 1200 µg AZD5423

dry powder inhaled via Turbuhaler, corr to approximately 200 µg lung deposited dose AZD5423

dry powder inhaled via New Dry Powder Inhaler, corr to approximately 200 µg lung deposited dose AZD5423